A Turning Point for Peptides? What RFK Jr.'s Announcement Could Mean for the Future of Wellness and Longevity Skytale Group The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA Peptide Regulation and HHS Policy Holt Law FDA Peptide Reclassification 2026: What It Means for Providers FDA Adds Several Peptides to Category 2 Bulks List, Restricting Them From Compounding Restore Health Consulting